The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
BMJ Open
(Sep 2020)
Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
Simon J Griffin,
Hajira Dambha-Miller,
Ali Albasri,
Christopher R Wilcox,
Sam Hodgson,
Shareen Khan
Affiliations
Simon J Griffin
1 MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, Cambridgeshire, UK
Hajira Dambha-Miller
Primary Care Research Centre, University of Southampton, Southampton, UK
Ali Albasri
research fellow
Christopher R Wilcox
Primary Care Research Centre, University of Southampton, Southampton, UK
Sam Hodgson
Department of Primary Care, University of Southampton, Southampton, UK
Shareen Khan
Oxford University Hospitals NHS Trust, Oxford, UK
DOI
https://doi.org/10.1136/bmjopen-2020-040644
Journal volume & issue
Vol. 10, no. 9
Abstract
Read online
No abstracts available.
WeChat QR code
Close